HomeInsightsPE

Caplin Point Laboratories Ltd PE Ratio

Caplin Point Laboratories Ltd PE Ratio

stocks purchased

₹ 1.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

5.1 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

PE

30.3

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Caplin Point Laboratories Ltd is 30.3 as of 24 Nov 15:30 PM .
  • The P/E Ratio of Caplin Point Laboratories Ltd changed from 17.2 on March 2019 to 21.9 on March 2024 . This represents a CAGR of 4.11% over 6 years.
  • The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 1964 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Caplin Point Laboratories Ltd

No data available

Company Fundamentals for Caplin Point Laboratories Ltd

No data available

Image

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

Share Price

₹ 1964.95

21.45 (1.10%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Caplin Point Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Caplin Point Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241964.95
21 Nov 20241943.5
19 Nov 20241951.3
18 Nov 20241985.35
14 Nov 20241952.65
13 Nov 20241952.95
12 Nov 20242009.45
11 Nov 20242010.35
08 Nov 20242010.85
07 Nov 20242117.5

SWOT Analysis Of Caplin Point Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Caplin Point Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Caplin Point Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Caplin Point Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Caplin Point Laboratories Ltd

No data available

* All values are in %

About Caplin Point Laboratories Ltd

  • Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990.
  • The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
  • Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
  • It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
  • In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

Caplin Point Laboratories Ltd News Hub

News

Volumes spurt at Caplin Point Laboratories Ltd counter

Hindustan Zinc Ltd, Godfrey Phillips India Ltd, Angel One Ltd, Triveni Engineering and Ind...

Read more

2024-08-19 00:00:00

News

Caplin Point Laboratories Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, Godfrey Phillips India Ltd, Gravita India Ltd and Poly Medicure ...

Read more

2024-08-19 00:00:00

News

Benchmarks trades with small gains; media shares in demand

The domestic equity benchmarks traded with decent gains in morning trade. The Nifty traded...

Read more

2024-08-19 00:00:00

News

Caplin Point hits life high after Chennai unit clears Brazilian Agency's inspection

ANVISA conducted an inspection of Caplin Steriles' injectable and ophthalmic manufacturing...

Read more

2024-08-19 00:00:00

News

Caplin Point Chennai unit clears Brazilian Agency's inspection

Caplin Point Laboratories informed that ANVISA conducted an inspection of Caplin Steriles'...

Read more

2024-08-17 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Caplin Point Laboratories Ltd

What is the current PE Ratio of Caplin Point Laboratories Ltd?

The Current PE Ratio of Caplin Point Laboratories Ltd is 30.26 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Caplin Point Laboratories Ltd last year?

The PE Ratio of Caplin Point Laboratories Ltd was 12.04 last year, now the PE ratio is 30.26, showing a year-on-year growth of 151.3%.

What does the PE Ratio of Caplin Point Laboratories Ltd indicate about its stock?

The PE Ratio of Caplin Point Laboratories Ltd is 30.26. This ratio indicates that investors are willing to pay 30.26 times the earnings per share for each share of Caplin Point Laboratories Ltd.

What is the PE Ratio Growth of Caplin Point Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Caplin Point Laboratories Ltd grew by 151.3% whereas, the EPS ratio grew by 5.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*